These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28829152)

  • 1. Lymphoproliferative Disorders of the Gastrointestinal Tract.
    Skinnider BF
    Arch Pathol Lab Med; 2018 Jan; 142(1):44-52. PubMed ID: 28829152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis.
    Burke JS
    Arch Pathol Lab Med; 2011 Oct; 135(10):1283-97. PubMed ID: 21970484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist.
    Owens SR
    Surg Pathol Clin; 2017 Dec; 10(4):1021-1037. PubMed ID: 29103531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
    Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
    Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
    Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
    Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK-Cell Enteropathy and Similar Indolent Lymphoproliferative Disorders: A Case Series With Literature Review.
    Xia D; Morgan EA; Berger D; Pinkus GS; Ferry JA; Zukerberg LR
    Am J Clin Pathol; 2019 Jan; 151(1):75-85. PubMed ID: 30212873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
    Wang XG; Yin WH; Wang HY
    Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma.
    McElroy MK; Read WL; Harmon GS; Weidner N
    Ann Diagn Pathol; 2011 Oct; 15(5):370-5. PubMed ID: 20952278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node involvement by enteropathy-like indolent NK-cell proliferation.
    Dargent JL; Tinton N; Trimech M; de Leval L
    Virchows Arch; 2021 Jun; 478(6):1197-1202. PubMed ID: 32696224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK-cell enteropathy, a potential diagnostic pitfall of intestinal lymphoproliferative disease.
    Wang R; Kariappa S; Toon CW; Varikatt W
    Pathology; 2019 Apr; 51(3):338-340. PubMed ID: 30819538
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunoglobulin heavy chain gene rearrangement study in difficult cases of B-cell lymphoproliferative disorder].
    Wang Q; Li XQ; Zhu XZ; Zhu XL; Lu HF; Zhang TM; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):296-301. PubMed ID: 20654151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell enteropathy: a case report with 10 years of indolent clinical behaviour.
    Isom JA; Arroyo MR; Reddy D; Joshi-Guske P; Al-Quran SZ; Li Y; Allan RW
    Histopathology; 2018 Aug; 73(2):345-350. PubMed ID: 29474745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic lymphoproliferative disorders].
    Salles G
    Rev Prat; 2002 May; 52(9):966-71. PubMed ID: 12063762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recognition and classification of lymphoproliferative disorders of the gut.
    O'Malley DP; Goldstein NS; Banks PM
    Hum Pathol; 2014 May; 45(5):899-916. PubMed ID: 24613566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach.
    Pizzi M; Sabattini E; Parente P; Bellan A; Doglioni C; Lazzi S
    Pathologica; 2020 Sep; 112(3):227-247. PubMed ID: 33179624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphomas and Amyloid in the Gastrointestinal Tract.
    Ware AD; Wake LM; Fedoriw Y
    Surg Pathol Clin; 2023 Dec; 16(4):719-743. PubMed ID: 37863562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Salient clinical features of lymphoma and related lymphoproliferative disorders].
    Fey MF
    Ther Umsch; 2010 Oct; 67(10):491-5. PubMed ID: 20886453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
    Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
    Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.